Leukemia Clinical Trials

Showing 6481-6500 of 8,366 trials

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

NCT01726296

This clinical trial studies adherence to survivorship care guidelines in health care providers for non-small cell lung cancer or colorectal cancer survivor care. The completion of an educational intervention by health care providers may increase compliance and adherence to National Comprehensive Cancer Network guidelines for survivorship care.

Adenocarcinoma of the LungMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+23 more

Fox Chase Cancer Center1,440 participantsStarted Jan 2013

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 2

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

NCT02227108

The primary objective of this study is to evaluate the efficacy of moxetumomab pasudotox in pediatric participants with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) or B-cell lymphoblastic lymphoma.

B-Cell Pediatric ALL

MedImmune LLC37 participantsStarted Aug 2014

Phoenix, Arizona, United States • Los Angeles, California, United States • Chicago, Illinois, United States +18 more locations

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Related Searches

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy

Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®)